Your browser doesn't support javascript.
loading
Benefits and Harms of Standard Versus Reduced-Dose Direct Oral Anticoagulant Therapy for Older Adults With Multiple Morbidities and Atrial Fibrillation.
Hayes, Kaleen N; Zhang, Tingting; Kim, Dae Hyun; Daiello, Lori A; Lee, Yoojin; Kiel, Douglas P; Berry, Sarah D; Zullo, Andrew R.
Affiliation
  • Hayes KN; Department of Health Services, Policy, and Practice Brown University School of Public Health Providence RI.
  • Zhang T; Graduate Department of Pharmaceutical Sciences University of Toronto Leslie Dan Faculty of Pharmacy Toronto ON Canada.
  • Kim DH; Department of Health Services, Policy, and Practice Brown University School of Public Health Providence RI.
  • Daiello LA; Hinda and Arthur Marcus Institute for Aging Research Hebrew SeniorLife and Harvard Medical School Boston MA.
  • Lee Y; Division of Gerontology, Department of Medicine Beth Israel Deaconess Medical Center and Harvard Medical School Boston MA.
  • Kiel DP; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA.
  • Berry SD; Department of Health Services, Policy, and Practice Brown University School of Public Health Providence RI.
  • Zullo AR; Department of Neurology Warren Alpert Medical School of Brown University and Alzheimer's Disease and Memory Disorders Center At Rhode Island Hospital Providence RI.
J Am Heart Assoc ; 12(21): e029865, 2023 11 07.
Article in En | MEDLINE | ID: mdl-37929769

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Am Heart Assoc Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Am Heart Assoc Year: 2023 Type: Article